-
Je něco špatně v tomto záznamu ?
Lipoblastoma-Like Tumor and Fibrosarcoma-Like Lipomatous Neoplasm Represent the Same Entity: A Clinicopathologic and Molecular Genetic Study of 23 Cases Occurring in Both Men and Women at Diverse Locations
JM. Gross, R. Perret, JM. Coindre, F. Le Loarer, M. Michal, M. Michal, M. Miettinen, CE. McCabe, AA. Nair, AA. Swanson, JJ. Thangaiah, J. Torres-Mora, A. Bonadio, L. Voltaggio, JI. Epstein, S. Gupta, AL. Folpe, JK. Schoolmeester
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
Grantová podpora
ZID BC011291
Intramural NIH HHS - United States
NLK
Free Medical Journals
od 2000 do Před 1 rokem
Open Access Digital Library
od 2000-01-01
ROAD: Directory of Open Access Scholarly Resources
od 1988
- MeSH
- dospělí MeSH
- fibrosarkom * MeSH
- lidé MeSH
- lipoblastom * genetika MeSH
- lipom * genetika patologie MeSH
- liposarkom * genetika MeSH
- molekulární biologie MeSH
- myxoidní liposarkom * MeSH
- nádorové biomarkery genetika MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
Lipoblastoma-like tumor (LLT) is a benign soft tissue tumor demonstrating mixed morphologic features of lipoblastoma, myxoid liposarcoma, and spindle cell lipoma but lacking genetic alterations associated with those tumors. LLT was originally thought to be specific to the vulva but has since been reported in the paratesticular region. The morphologic features of LLT overlap with those of "fibrosarcoma-like lipomatous neoplasm" (FLLN), a rare, indolent adipocytic neoplasm considered by some to form part of the spectrum of atypical spindle cell and pleomorphic lipomatous tumor. We compared the morphologic, immunohistochemical, and genetic features of 23 tumors previously classified as LLT (n = 17) and FLLN (n = 6). The 23 tumors occurred in 13 women and 10 men (mean age, 42 years; range, 17 to 80 years). Eighteen (78%) cases arose in the inguinogenital region, whereas 5 tumors (22%) involved noninguinogenital soft tissue, including the flank (n = 1), shoulder (n = 1), foot (n = 1), forearm (n = 1), and chest wall (n = 1). Microscopically, the tumors were lobulated and septated, with variably collagenized fibromyxoid stroma, prominent thin-walled vessels, scattered univacuolated or bivacuolated lipoblasts, and a minor component of mature adipose tissue. Using immunohistochemistry, 5 tumors (42%) showed complete RB1 loss, with partial loss in 7 cases (58%). RNA sequencing, chromosomal microarray, and DNA next-generation sequencing study results were negative for significant alterations. There were no clinical, morphologic, immunohistochemical, or molecular genetic differences between cases previously classified as LLT or FLLN. Clinical follow-up (11 patients [48%]; range, 2-276 months; mean, 48.2 months) showed all patients were alive without disease, and only one patient had experienced a single local recurrence. We conclude that LLT and FLLN represent the same entity, for which "LLT" seems most appropriate. LLT may occur in either sex and any superficial soft tissue location. Careful morphologic study and appropriate ancillary testing should allow for the distinction of LLT from its potential mimics.
Bordeaux Institute of Oncology Université de Bordeaux Institut Bergonié Bordeaux France
Department of Biopathology Institut Bergonié Comprehensive Cancer Center Bordeaux France
Department of Laboratory Medicine and Pathology Mayo Clinic Jacksonville Florida
Department of Laboratory Medicine and Pathology Mayo Clinic Rochester Minnesota
Department of Pathology Faculty of Medicine in Pilsen Charles University Pilsen Czech Republic
Department of Pathology Johns Hopkins School of Medicine Baltimore Maryland
Laboratory of Pathology National Cancer Institute National Institutes of Health Bethesda Maryland
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23016415
- 003
- CZ-PrNML
- 005
- 20231026105900.0
- 007
- ta
- 008
- 231013s2023 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.modpat.2023.100246 $2 doi
- 035 __
- $a (PubMed)37307874
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Gross, John M $u Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland
- 245 10
- $a Lipoblastoma-Like Tumor and Fibrosarcoma-Like Lipomatous Neoplasm Represent the Same Entity: A Clinicopathologic and Molecular Genetic Study of 23 Cases Occurring in Both Men and Women at Diverse Locations / $c JM. Gross, R. Perret, JM. Coindre, F. Le Loarer, M. Michal, M. Michal, M. Miettinen, CE. McCabe, AA. Nair, AA. Swanson, JJ. Thangaiah, J. Torres-Mora, A. Bonadio, L. Voltaggio, JI. Epstein, S. Gupta, AL. Folpe, JK. Schoolmeester
- 520 9_
- $a Lipoblastoma-like tumor (LLT) is a benign soft tissue tumor demonstrating mixed morphologic features of lipoblastoma, myxoid liposarcoma, and spindle cell lipoma but lacking genetic alterations associated with those tumors. LLT was originally thought to be specific to the vulva but has since been reported in the paratesticular region. The morphologic features of LLT overlap with those of "fibrosarcoma-like lipomatous neoplasm" (FLLN), a rare, indolent adipocytic neoplasm considered by some to form part of the spectrum of atypical spindle cell and pleomorphic lipomatous tumor. We compared the morphologic, immunohistochemical, and genetic features of 23 tumors previously classified as LLT (n = 17) and FLLN (n = 6). The 23 tumors occurred in 13 women and 10 men (mean age, 42 years; range, 17 to 80 years). Eighteen (78%) cases arose in the inguinogenital region, whereas 5 tumors (22%) involved noninguinogenital soft tissue, including the flank (n = 1), shoulder (n = 1), foot (n = 1), forearm (n = 1), and chest wall (n = 1). Microscopically, the tumors were lobulated and septated, with variably collagenized fibromyxoid stroma, prominent thin-walled vessels, scattered univacuolated or bivacuolated lipoblasts, and a minor component of mature adipose tissue. Using immunohistochemistry, 5 tumors (42%) showed complete RB1 loss, with partial loss in 7 cases (58%). RNA sequencing, chromosomal microarray, and DNA next-generation sequencing study results were negative for significant alterations. There were no clinical, morphologic, immunohistochemical, or molecular genetic differences between cases previously classified as LLT or FLLN. Clinical follow-up (11 patients [48%]; range, 2-276 months; mean, 48.2 months) showed all patients were alive without disease, and only one patient had experienced a single local recurrence. We conclude that LLT and FLLN represent the same entity, for which "LLT" seems most appropriate. LLT may occur in either sex and any superficial soft tissue location. Careful morphologic study and appropriate ancillary testing should allow for the distinction of LLT from its potential mimics.
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 12
- $a lipoblastom $x genetika $7 D062689
- 650 _2
- $a nádorové biomarkery $x genetika $7 D014408
- 650 12
- $a lipom $x genetika $x patologie $7 D008067
- 650 12
- $a liposarkom $x genetika $7 D008080
- 650 12
- $a fibrosarkom $7 D005354
- 650 12
- $a myxoidní liposarkom $7 D018208
- 650 _2
- $a molekulární biologie $7 D008967
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Perret, Raul $u Department of Biopathology, Institut Bergonié, Comprehensive Cancer Center, Bordeaux, France; Bordeaux Institute of Oncology, Université de Bordeaux, Institut Bergonié, Bordeaux, France
- 700 1_
- $a Coindre, Jean Michel $u Department of Biopathology, Institut Bergonié, Comprehensive Cancer Center, Bordeaux, France; Bordeaux Institute of Oncology, Université de Bordeaux, Institut Bergonié, Bordeaux, France; University of Bordeaux, Talence, France
- 700 1_
- $a Le Loarer, Francois $u Department of Biopathology, Institut Bergonié, Comprehensive Cancer Center, Bordeaux, France; Bordeaux Institute of Oncology, Université de Bordeaux, Institut Bergonié, Bordeaux, France; University of Bordeaux, Talence, France
- 700 1_
- $a Michal, Michael $u Department of Pathology, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic
- 700 1_
- $a Michal, Michal $u Department of Pathology, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic
- 700 1_
- $a Miettinen, Markku $u Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- 700 1_
- $a McCabe, Chantal E $u Department of Quantitative Health Sciences, Division of Computational Biology, Mayo Clinic, Rochester, Minnesota
- 700 1_
- $a Nair, Asha A $u Department of Quantitative Health Sciences, Division of Computational Biology, Mayo Clinic, Rochester, Minnesota
- 700 1_
- $a Swanson, Amy A $u Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota
- 700 1_
- $a Thangaiah, Judith J $u Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota
- 700 1_
- $a Torres-Mora, Jorge $u Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota
- 700 1_
- $a Bonadio, Angelo $u Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy
- 700 1_
- $a Voltaggio, Lysandra $u Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland
- 700 1_
- $a Epstein, Jonathan I $u Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland
- 700 1_
- $a Gupta, Sounak $u Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota
- 700 1_
- $a Folpe, Andrew L $u Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota
- 700 1_
- $a Schoolmeester, J Kenneth $u Department of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, Florida. Electronic address: schoolmeester.j@mayo.edu
- 773 0_
- $w MED00003380 $t Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc $x 1530-0285 $g Roč. 36, č. 9 (2023), s. 100246
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37307874 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20231013 $b ABA008
- 991 __
- $a 20231026105854 $b ABA008
- 999 __
- $a ok $b bmc $g 2000122 $s 1202777
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 36 $c 9 $d 100246 $e 20230610 $i 1530-0285 $m Modern pathology $n Mod Pathol $x MED00003380
- GRA __
- $a ZID BC011291 $p Intramural NIH HHS $2 United States
- LZP __
- $a Pubmed-20231013